Physician profile
Mark Bridges
NPI 1225091143
$687.73
in general payments reported to CMS, 2019-2025
9 companies · $95.19 in 2025
The $95.19 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $113 · 2021: $51.11 · 2022: $26.21 · 2024: $133 · 2025: $95.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $293.30 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $126.98 | 2024-2025 | Mymobility Platform, Tricera Handpiece |
| Ermi LLC | $57.98 | 2020 | |
| Ferring Pharmaceuticals INC. | $56.86 | 2019 | |
| Depuy Synthes Sales INC. | $43.46 | 2020-2024 | Monovisc, Orthovisc |
| Stryker Corporation | $33.74 | 2019 | |
| Electronic Waveform Lab, INC. | $28.96 | 2025 | |
| Abbvie INC. | $28.06 | 2024 | |
| Ibsa Pharma INC. | $18.39 | 2024 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.